| 2025-05-06 | +10.6% | earnings | Seeking Alpha | Fresenius Medical Care Non-GAAP EPS of 0.84, revenue of 4.88B; reaffirms FY25 outlook |
| 2026-01-13 | -9.6% | news | Seeking Alpha | Fresenius Medical Care AG (FMS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript |
| 2026-02-24 | -9.5% | earnings | Seeking Alpha | Fresenius Medical Care AG (FMS) Q4 2025 Earnings Call Transcript |
| 2026-02-24 | -9.5% | earnings | Seeking Alpha | Fresenius Medical Care AG 2025 Q4 - Results - Earnings Call Presentation |
| 2026-02-24 | -9.5% | earnings | Seeking Alpha | Fresenius Medical Care Non-GAAP EPS of 1.44, revenue of 5.07B; introduces FY26 and long-term outlook |
| 2025-11-04 | -7.1% | earnings | Seeking Alpha | Fresenius Medical Care AG (FMS) Q3 2025 Earnings Call Transcript |
| 2025-11-04 | -7.1% | earnings | Seeking Alpha | Fresenius Medical Care gives Q3 numbers |
| 2026-02-23 | -6.8% | earnings | Seeking Alpha | Fresenius Medical Care Q4 2025 Earnings Preview |
| 2025-08-05 | -5.9% | earnings | Seeking Alpha | Fresenius Medical Care AG (FMS) Q2 2025 Earnings Call Transcript |
| 2025-08-05 | -5.9% | earnings | Seeking Alpha | Fresenius Medical Care reports Q2 results |
| 2025-08-05 | -5.9% | earnings | Investing.com Canada | Fresenius Medical Care ADR earnings beat by $0.41, revenue fell short of estimates - Investing.com Canada |
| 2026-04-14 | -5.7% | news | Stock Titan | Fresenius Medical Care (NYSE: FMS) plans €1.49 dividend and renews 10% buyback mandate - Stock Titan |
| 2024-11-15 | +4.6% | news | Seeking Alpha | Medtech shouldn't be greatly impacted by RFK Jr. at HHS, Wells Fargo says |
| 2025-06-17 | -4.5% | news | Seeking Alpha | Fresenius Medical Care initiates 1B share buyback |
| 2026-01-21 | +4.1% | news | Morningstar | 18 of the Best Stocks and ETFs to Buy Based on 2026 Expert Forecasts - Morningstar |
| 2026-03-31 | -3.1% | news | Insider Monkey | Here’s Why Fresenius Medical Care AG (FMS) Remains Attractive |
| 2026-03-25 | +2.9% | news | Zacks | Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now |
| 2026-01-29 | +2.8% | news | Seeking Alpha | Fresenius Medical Care: Low Confidence On Growth Acceleration Limits Upside |
| 2025-07-22 | +2.6% | news | Seeking Alpha | Fresenius Medical Care: Is Trading Below Its Intrinsic Value (Buy) |
| 2026-03-10 | -2.5% | expansion | Morningstar | Fresenius Medical Care Faces a Transition Year in 2026 on New Product Launch Activities - Morningstar |
| 2025-04-27 | +2.5% | news | Seeking Alpha | Fresenius: Holding On For Longer-Term Growth Driven By Demand In Kidney Care Segment |
| 2025-03-26 | +1.9% | legal | Seeking Alpha | Fresenius gets FDA approval for biosimilars of Amgen's bone-condition drugs |
| 2026-04-21 | -1.7% | earnings | MarketBeat | Quest Diagnostics Q1 Earnings Call Highlights |
| 2026-04-07 | +1.6% | news | Simply Wall St. | Is Fresenius Medical Care (XTRA:FME) Now Attractively Priced After Years Of Share Price Weakness? |
| 2025-02-25 | +1.5% | analyst | Seeking Alpha | Fresenius targets high teens to high 20s operating income growth for 2025 amid transformation progress |
| 2025-02-25 | +1.5% | earnings | Seeking Alpha | Fresenius Medical Care AG (FMS) Q4 2024 Earnings Conference Call Transcript |
| 2025-02-25 | +1.5% | earnings | Seeking Alpha | Fresenius Medical Care Non-GAAP EPS of 0.91, revenue of 5.99B; initiates FY25 outlook |
| 2023-10-13 | +1.5% | news | Morningstar | The 10 Best International Stocks to Buy - Morningstar |
| 2025-05-02 | +1.5% | news | Seeking Alpha | Fresenius Medical Care: Why I'm Not (Yet) Biting Despite Turnaround Progress |
| 2024-11-05 | +1.5% | earnings | Seeking Alpha | Fresenius Medical Care AG (FMS) Q3 2024 Earnings Call Transcript |
| 2026-03-24 | +1.4% | news | Zacks | Fresenius (FMS) is a Top-Ranked Value Stock: Should You Buy? |
| 2025-07-03 | -1.3% | executive | Seeking Alpha | Fresenius Medical in pact with Coordination of National Institutes in Mexico |
| 2025-11-25 | -1.3% | news | Seeking Alpha | Fresenius Medical Care: 'Buy' Again Following A Peak In May |
| 2026-03-23 | +1.1% | news | Morningstar | 10 New 5-Star Stocks This Week - Morningstar |
| 2025-01-31 | -0.9% | news | Seeking Alpha | Fresenius Medical Care: A 'Buy' Going Into 2025 |
| 2024-04-02 | -0.8% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2025-01-20 | -0.8% | news | Fresenius Medical Care | Basic share data - Fresenius Medical Care |
| 2026-02-27 | +0.7% | earnings | Morningstar | 5 Undervalued Stocks That Crushed Q4 Earnings - Morningstar |
| 2026-03-02 | +0.4% | news | Morningstar | Fresenius Medical Care: An Undervalued Stock to Buy Now and Hold for the Long Term - Morningstar |
| 2026-04-09 | +0.3% | news | Zacks | Why Fresenius (FMS) is a Top Value Stock for the Long-Term |
| 2026-04-09 | +0.3% | news | TMX Newsfile | Focus Graphite Initiates Joint Development with Forge Nano to Evaluate Advanced Coating Technology for Lac Knife Graphite |
| 2024-11-09 | +0.3% | news | Seeking Alpha | Assessing MedTech impact from potential China tariffs |
| 2025-07-29 | +0.3% | news | Sure Dividend | The Top 10 International Dividend Stocks, Ranked In Order - Sure Dividend |
| 2025-11-06 | -0.1% | earnings | Seeking Alpha | Fresenius Medical Care AG 2025 Q3 - Results - Earnings Call Presentation |
| 2025-05-08 | -0.0% | earnings | Seeking Alpha | Fresenius Medical Care AG 2025 Q1 - Results - Earnings Call Presentation |
| 2025-05-08 | -0.0% | analyst | Seeking Alpha | Fresenius medical care outlines 2025 operating income growth targets amid strategic transformations |
| 2025-05-08 | -0.0% | earnings | Seeking Alpha | Fresenius Medical Care AG (FMS) Q1 2025 Earnings Conference Call Transcript |
| 2026-04-02 | +0.0% | news | TMX Newsfile | Fundamental Research Corp. Initiates Coverage on Focus Graphite Inc. |
| 2026-04-24 | — | news | MT Newswires | Humacyte Realigns Ex-US Rights to Symvess With Fresenius Medical Care |
| 2026-04-24 | — | news | GlobeNewswire | Humacyte Expands Commercial and Business Development Opportunities Through Realignment of Ex-U.S. Rights to Symvess® |
| 2026-04-24 | — | news | Seeking Alpha | Humacyte regains ex-U.S. rights to Symvess from Fresenius Medical Care |